R&D A practical route through regulatory uncertainty in clinical... Organisations must remain agile and decisive across global portfolios, anticipating regulatory changes before they create clinical trial delays.
R&D The reasoning problem In R&D, decisions that matter most rarely happen during the documented steps; they happen in the pauses between them.
R&D European launch: Manufacturing as cornerstone for success In Europe, manufacturing may not make headlines in pharma partnering, but it’s one of the foundations on which strong partnerships must be built.
R&D CAMP4 on a new class of ASO in gene under expression CAMP4 Therapeutics CFO Kelly Gold discusses developments in antisense oligonucleotides and CAMP4’s CMP-002 study
News ESMO26: Zai and Ideaya showcase DLL3 drugs in lung cancer Two drugs hoping to muscle in Amgen's first-to-market DLL3-targeting drug Imdelltra – from Zai Lab and Ideaya – have new trial readouts at ESMO.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
